As of May 26
| -0.18 / -2.76%|
The 4 analysts offering 12-month price forecasts for Genesis Healthcare Inc have a median target of 8.50, with a high estimate of 11.00 and a low estimate of 8.00. The median estimate represents a +34.28% increase from the last price of 6.33.
The current consensus among 4 polled investment analysts is to Hold stock in Genesis Healthcare Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.